Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.09 0.00 (-2.58%) As of 05/1/2025 01:14 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock Provectus Biopharmaceuticals Stock Price Performance 5 Day Performance-5.83%1 Month Performance-9.23%3 Month Performance-14.30%6 Month Performance-12.31%Year-To-Date Performance-24.65%1 Year Performance-52.69% Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PVCT Stock Chart for Friday, May, 2, 2025 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$0.09$0.09-2.58%$0.09$0.09112,800 shs$38.04 million04/30/2025$0.09$0.09+6.17%$0.09$0.0930,100 shs$39.04 million04/29/2025$0.08$0.09+4.17%$0.09$0.0839,247 shs$36.77 million04/28/2025$0.10$0.08-12.59%$0.10$0.08825,577 shs$35.30 million04/25/2025$0.10$0.10-0.93%$0.10$0.09154,480 shs$40.39 million04/24/2025$0.10$0.10-2.02%$0.10$0.0983,100 shs$40.77 million04/23/2025$0.10$0.10+2.91%$0.10$0.1050,000 shs$41.61 million04/22/2025$0.09$0.10+4.23%$0.10$0.0918,577 shs$40.43 million04/21/2025$0.10$0.09-4.75%$0.10$0.09216,450 shs$38.79 million04/18/2025$0.10$0.10$0.10$0.0957,070 shs$40.73 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$0.10$0.10-0.72%$0.10$0.0957,070 shs$40.73 million04/16/2025$0.10$0.10-0.91%$0.10$0.09110,200 shs$41.02 million04/15/2025$0.10$0.10+3.68%$0.10$0.105,100 shs$41.40 million04/14/2025$0.10$0.10-4.04%$0.10$0.09329,407 shs$39.93 million04/11/2025$0.10$0.10+3.02%$0.10$0.1031,218 shs$41.61 million04/10/2025$0.10$0.10-2.93%$0.10$0.09160,166 shs$40.39 million04/09/2025$0.10$0.10+1.23%$0.10$0.10106,000 shs$41.61 million04/09/2025$0.10$0.10+1.23%$0.10$0.10106,000 shs$41.61 million04/08/2025$0.10$0.10-1.61%$0.10$0.10330,734 shs$41.10 million04/08/2025$0.10$0.10-1.61%$0.10$0.10330,734 shs$41.10 million04/07/2025$0.10$0.10+2.26%$0.10$0.0961,396 shs$41.78 million04/04/2025$0.10$0.10+0.52%$0.10$0.09397,895 shs$40.85 million04/03/2025$0.10$0.10-3.01%$0.10$0.09352,144 shs$40.64 million04/02/2025$0.10$0.10-0.20%$0.10$0.0916,698 shs$41.90 million04/01/2025$0.10$0.10-0.10%$0.10$0.0999,390 shs$41.99 million Related Companies OGI Stock Price Chart EPRX Stock Price Chart CYBN Stock Price Chart ADCT Stock Price Chart SLS Stock Price Chart CGEN Stock Price Chart FTLF Stock Price Chart EDIT Stock Price Chart LXEO Stock Price Chart LYEL Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PVCT Stock Free PVCT Stock Alerts